SENSEX
NIFTY
GOLD
USD/INR

Weather

image 33    C

Top News News

The Hindu

Top News / The Hindu

details

What's the deal with peptides? The hyped market under U.S. review

The substances under review -- including BPC-157, TB-500 and Semax -- are among those Joe Biden's administration restricted from compounding, notably over lack of human clinical trial data

23 Jul 2026 1:27 pm